• レポートコード:QY20ST-06611 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、139ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界のED治療市場について種類別(シルデナフィル、タダラフィル、その他)、用途別(病院、ドラッグストア、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ED治療市場の概要 ・世界の主要地域別ED治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のED治療市場規模2015-2026:種類別(シルデナフィル、タダラフィル、その他) ・世界のED治療市場規模2015-2026:用途別(病院、ドラッグストア、その他) ・ED治療の北米市場規模2015-2020 ・ED治療のヨーロッパ市場規模2015-2020 ・ED治療の中国市場規模2015-2020 ・ED治療の日本市場規模2015-2020 ・ED治療の東南アジア市場規模2015-2020 ・ED治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・ED治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ED治療の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global ED Treatment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global ED Treatment market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the ED Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the ED Treatment industry.
Based on our recent survey, we have several different scenarios about the ED Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of ED Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global ED Treatment market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global ED Treatment market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global ED Treatment market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global ED Treatment market. The report also includes nautical information, where it shows ED Treatment market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global ED Treatment market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global ED Treatment market.
Geographical Analysis:
Based on region, the global ED Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global ED Treatment market are
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospitals
Drugstores
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global ED Treatment market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global ED Treatment market.
• The market share of the global ED Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global ED Treatment market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global ED Treatment market.
1 ED Treatment Market Overview
1.1 ED Treatment Product Scope
1.2 ED Treatment Segment by Type
1.2.1 Global ED Treatment Sales by Type (2020-2026)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 ED Treatment Segment by Application
1.3.1 Global ED Treatment Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 ED Treatment Market Estimates and Forecasts (2015-2026)
1.4.1 Global ED Treatment Sales Growth Rate (2015-2026)
1.4.2 Global ED Treatment Revenue and Growth Rate (2015-2026)
1.4.3 Global ED Treatment Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): ED Treatment Industry Impact
1.5.1 How the Covid-19 is Affecting the ED Treatment Industry
1.5.1.1 ED Treatment Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and ED Treatment Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for ED Treatment Players to Combat Covid-19 Impact
2 ED Treatment Estimate and Forecast by Region
2.1 Global ED Treatment Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global ED Treatment Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global ED Treatment Sales Market Share by Region (2015-2020)
2.2.2 Global ED Treatment Revenue Market Share by Region (2015-2020)
2.3 Global ED Treatment Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global ED Treatment Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global ED Treatment Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States ED Treatment Estimates and Projections (2015-2026)
2.4.2 Europe ED Treatment Estimates and Projections (2015-2026)
2.4.3 China ED Treatment Estimates and Projections (2015-2026)
2.4.4 Japan ED Treatment Estimates and Projections (2015-2026)
2.4.5 Southeast Asia ED Treatment Estimates and Projections (2015-2026)
2.4.6 India ED Treatment Estimates and Projections (2015-2026)
3 Global ED Treatment Competition Landscape by Players
3.1 Global Top ED Treatment Players by Sales (2015-2020)
3.2 Global Top ED Treatment Players by Revenue (2015-2020)
3.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ED Treatment as of 2019)
3.4 Global ED Treatment Average Price by Company (2015-2020)
3.5 Manufacturers ED Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key ED Treatment Players (Opinion Leaders)
4 Global ED Treatment Market Size by Type
4.1 Global ED Treatment Historic Market Review by Type (2015-2020)
4.1.1 Global ED Treatment Sales Market Share by Type (2015-2020)
4.1.2 Global ED Treatment Revenue Market Share by Type (2015-2020)
4.1.3 Global ED Treatment Price by Type (2014-2020)
4.2 Global ED Treatment Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global ED Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global ED Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Global ED Treatment Price Forecast by Type (2021-2026)
5 Global ED Treatment Market Size by Application
5.1 Global ED Treatment Historic Market Review by Application (2015-2020)
5.1.1 Global ED Treatment Sales Market Share by Application (2015-2020)
5.1.2 Global ED Treatment Revenue Market Share by Application (2015-2020)
5.1.3 Global ED Treatment Price by Application (2015-2020)
5.2 Global ED Treatment Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global ED Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global ED Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global ED Treatment Price Forecast by Application (2021-2026)
3 North America ED Treatment Market Facts & Figures
3.2 North America ED Treatment Sales Market Share by Company (2015-2020)
3.3 North America ED Treatment Sales Market Share by Type (2015-2020)
3.4 North America ED Treatment Sales Market Share by Application (2015-2020)
4 Europe ED Treatment Market Facts & Figures
4.2 Europe ED Treatment Sales Market Share by Company (2015-2020)
4.3 Europe ED Treatment Sales Market Share by Type (2015-2020)
4.4 Europe ED Treatment Sales Market Share by Application (2015-2020)
5 China ED Treatment Market Facts & Figures
5.2 China ED Treatment Sales Market Share by Company (2015-2020)
5.3 China ED Treatment Sales Market Share by Type (2015-2020)
5.4 China ED Treatment Sales Market Share by Application (2015-2020)
6 Japan ED Treatment Market Facts & Figures
6.2 Japan ED Treatment Sales Market Share by Company (2015-2020)
6.3 Japan ED Treatment Sales Market Share by Type (2015-2020)
6.4 Japan ED Treatment Sales Market Share by Application (2015-2020)
7 Southeast Asia ED Treatment Market Facts & Figures
7.2 Southeast Asia ED Treatment Sales Market Share by Company (2015-2020)
7.3 Southeast Asia ED Treatment Sales Market Share by Type (2015-2020)
7.4 Southeast Asia ED Treatment Sales Market Share by Application (2015-2020)
8 India ED Treatment Market Facts & Figures
8.2 India ED Treatment Sales Market Share by Company (2015-2020)
8.3 India ED Treatment Sales Market Share by Type (2015-2020)
8.4 India ED Treatment Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in ED Treatment Business
12.1 Eli Lilly
12.1.1 Eli Lilly ED Treatment Corporation Information
12.1.2 Eli Lilly ED Treatment Business Overview and Total Revenue
12.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly ED Treatment Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer ED Treatment Corporation Information
12.2.2 Pfizer ED Treatment Business Overview and Total Revenue
12.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer ED Treatment Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer ED Treatment Corporation Information
12.3.2 Bayer ED Treatment Business Overview and Total Revenue
12.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer ED Treatment Products Offered
12.3.5 Bayer Recent Development
12.4 BaiYunShan General Factory
12.4.1 BaiYunShan General Factory ED Treatment Corporation Information
12.4.2 BaiYunShan General Factory ED Treatment Business Overview and Total Revenue
12.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BaiYunShan General Factory ED Treatment Products Offered
12.4.5 BaiYunShan General Factory Recent Development
12.5 S.K. Chemicals
12.5.1 S.K. Chemicals ED Treatment Corporation Information
12.5.2 S.K. Chemicals ED Treatment Business Overview and Total Revenue
12.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.5.4 S.K. Chemicals ED Treatment Products Offered
12.5.5 S.K. Chemicals Recent Development
12.6 Teva Pharma
12.6.1 Teva Pharma ED Treatment Corporation Information
12.6.2 Teva Pharma ED Treatment Business Overview and Total Revenue
12.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharma ED Treatment Products Offered
12.6.5 Teva Pharma Recent Development
12.7 Dong-A ST
12.7.1 Dong-A ST ED Treatment Corporation Information
12.7.2 Dong-A ST ED Treatment Business Overview and Total Revenue
12.7.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dong-A ST ED Treatment Products Offered
12.7.5 Dong-A ST Recent Development
12.8 Metuchen Pharma
12.8.1 Metuchen Pharma ED Treatment Corporation Information
12.8.2 Metuchen Pharma ED Treatment Business Overview and Total Revenue
12.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Metuchen Pharma ED Treatment Products Offered
12.8.5 Metuchen Pharma Recent Development
12.9 Seoul Pharma
12.9.1 Seoul Pharma ED Treatment Corporation Information
12.9.2 Seoul Pharma ED Treatment Business Overview and Total Revenue
12.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Seoul Pharma ED Treatment Products Offered
12.9.5 Seoul Pharma Recent Development
12.10 CSBIO.
12.10.1 CSBIO. ED Treatment Corporation Information
12.10.2 CSBIO. ED Treatment Business Overview and Total Revenue
12.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CSBIO. ED Treatment Products Offered
12.10.5 CSBIO. Recent Development
13 ED Treatment Manufacturing Cost Analysis
13.1 ED Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of ED Treatment
13.4 ED Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 ED Treatment Distributors List
14.3 ED Treatment Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global ED Treatment Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global ED Treatment Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four ED Treatment Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for ED Treatment Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for ED Treatment Players to Combat Covid-19 Impact
Table 8. Global Market ED Treatment Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global ED Treatment Sales (K Units) by Region (2015-2020)
Table 10. Global ED Treatment Sales Market Share by Region (2015-2020)
Table 11. Global ED Treatment Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global ED Treatment Revenue Share by Region (2015-2020)
Table 13. Global ED Treatment Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global ED Treatment Sales Market Share Forecast by Region (2021-2026)
Table 15. Global ED Treatment Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global ED Treatment Revenue Share Forecast by Region (2021-2026)
Table 17. Global ED Treatment (K Units) of Key Companies (2015-2020)
Table 18. Global ED Treatment Sales Share by Company (2015-2020)
Table 19. Global ED Treatment Revenue (US$ Million) by Company (2015-2020)
Table 20. Global ED Treatment Revenue Share by Company (2015-2020)
Table 21. Global ED Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ED Treatment as of 2019)
Table 22. Global ED Treatment Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers ED Treatment Manufacturing Sites and Area Served
Table 24. Manufacturers ED Treatment Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key ED Treatment Players
Table 27. Global ED Treatment Sales (K Units) by Type (2015-2020)
Table 28. Global ED Treatment Sales Share by Type (2015-2020)
Table 29. Global ED Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global ED Treatment Price (K Units) by Type (2015-2020)
Table 31. Global ED Treatment Sales Share by Type (2021-2026)
Table 32. Global ED Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global ED Treatment Revenue Share by Type (2021-2026)
Table 34. Global ED Treatment Price (K Units) by Type (2021-2026)
Table 35. Global ED Treatment Sales (K Units) by Application (2015-2020)
Table 36. Global ED Treatment Sales Share by Application (2015-2020)
Table 37. Global ED Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global ED Treatment Price (K Units) by Application (2015-2020)
Table 39. Global ED Treatment Sales (K Units) by Application (2021-2026)
Table 40. Global ED Treatment Sales Share by Application (2021-2026)
Table 41. Global ED Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global ED Treatment Revenue Share by Application (2021-2026)
Table 43. Global ED Treatment Price (K Units) by Application (2021-2026)
Table 44. United States ED Treatment Sales (K Units) by Company (2015-2020)
Table 45. United States ED Treatment Sales Market Share by Company (2015-2020)
Table 46. United States ED Treatment Sales (K Units) by Type (2015-2020)
Table 47. United States ED Treatment Sales Market Share by Type (2015-2020)
Table 48. United States ED Treatment Sales (K Units) by Application (2015-2020)
Table 49. United States ED Treatment Sales Market Share by Application (2015-2020)
Table 50. Europe ED Treatment Sales (K Units) by Company (2015-2020)
Table 51. Europe ED Treatment Sales Market Share by Company (2015-2020)
Table 52. Europe ED Treatment Sales (K Units) by Type (2015-2020)
Table 53. Europe ED Treatment Sales Market Share by Type (2015-2020)
Table 54. Europe ED Treatment Sales (K Units) by Application (2015-2020)
Table 55. Europe ED Treatment Sales Market Share by Type (2015-2020)
Table 56. China ED Treatment Sales (K Units) by Company (2015-2020)
Table 57. China ED Treatment Sales Market Share by Company (2015-2020)
Table 58. China ED Treatment Sales (K Units) by Type (2015-2020)
Table 59. China ED Treatment Sales Market Share by Type (2015-2020)
Table 60. China ED Treatment Sales (K Units) by Application (2015-2020)
Table 61. China ED Treatment Sales Market Share by Application (2015-2020)
Table 62. Japan ED Treatment Sales (K Units) by Company (2015-2020)
Table 63. Japan ED Treatment Sales Market Share by Company (2015-2020)
Table 64. Japan ED Treatment Sales (K Units) by Type (2015-2020)
Table 65. Japan ED Treatment Sales Market Share by Type (2015-2020)
Table 66. Japan ED Treatment Sales (K Units) by Application (2015-2020)
Table 67. Japan ED Treatment Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia ED Treatment Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia ED Treatment Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia ED Treatment Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia ED Treatment Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia ED Treatment Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia ED Treatment Sales Market Share by Application (2015-2020)
Table 74. India ED Treatment Sales (K Units) by Company (2015-2020)
Table 75. India ED Treatment Sales Market Share by Company (2015-2020)
Table 76. India ED Treatment Sales (K Units) by Type (2015-2020)
Table 77. India ED Treatment Sales Market Share by Type (2015-2020)
Table 78. India ED Treatment Sales (K Units) by Application (2015-2020)
Table 79. India ED Treatment Sales Market Share by Application (2015-2020)
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eli Lilly ED Treatment Product
Table 84. Eli Lilly Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer ED Treatment Product
Table 89. Pfizer Recent Development
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Bayer ED Treatment Product
Table 94. Bayer Recent Development
Table 95. BaiYunShan General Factory Corporation Information
Table 96. BaiYunShan General Factory Description and Business Overview
Table 97. BaiYunShan General Factory ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. BaiYunShan General Factory ED Treatment Product
Table 99. BaiYunShan General Factory Recent Development
Table 100. S.K. Chemicals Corporation Information
Table 101. S.K. Chemicals Description and Business Overview
Table 102. S.K. Chemicals ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. S.K. Chemicals ED Treatment Product
Table 104. S.K. Chemicals Recent Development
Table 105. Teva Pharma Corporation Information
Table 106. Teva Pharma Description and Business Overview
Table 107. Teva Pharma ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Teva Pharma ED Treatment Product
Table 109. Teva Pharma Recent Development
Table 110. Dong-A ST Corporation Information
Table 111. Dong-A ST Description and Business Overview
Table 112. Dong-A ST ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Dong-A ST ED Treatment Product
Table 114. Dong-A ST Recent Development
Table 115. Metuchen Pharma Corporation Information
Table 116. Metuchen Pharma ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Metuchen Pharma Description and Business Overview
Table 118. Metuchen Pharma ED Treatment Product
Table 119. Metuchen Pharma Recent Development
Table 120. Seoul Pharma Corporation Information
Table 121. Seoul Pharma ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Seoul Pharma Description and Business Overview
Table 123. Seoul Pharma ED Treatment Product
Table 124. Seoul Pharma Recent Development
Table . CSBIO. Corporation Information
Table . CSBIO. Description and Business Overview
Table . CSBIO. ED Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . CSBIO. ED Treatment Product
Table . CSBIO. Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. ED Treatment Distributors List
Table 133. ED Treatment Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. ED Treatment Product Picture
Figure 2. Global ED Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global ED Treatment Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Drugstores Examples
Figure 8. Other Examples
Figure 9. Global ED Treatment Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global ED Treatment Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global ED Treatment Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global ED Treatment Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global ED Treatment Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States ED Treatment Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe ED Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China ED Treatment Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan ED Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia ED Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India ED Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India ED Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest ED Treatment Players Market Share by Revenue in ED Treatment 2015 & 2019
Figure 27. ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global ED Treatment Revenue Share by Type (2015-2020)
Figure 29. Global ED Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global ED Treatment Revenue Share by Application (2015-2020)
Figure 31. Global ED Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States ED Treatment Sales Market Share by Type in 2019
Figure 33. United States ED Treatment Sales Market Share by Type in 2019
Figure 34. Europe ED Treatment Sales Market Share by Company in 2019
Figure 35. Europe ED Treatment Sales Market Share by Type in 2019
Figure 36. Europe ED Treatment Sales Market Share by Application in 2019
Figure 37. China ED Treatment Sales Market Share by Company in 2019
Figure 38. China ED Treatment Sales Market Share by Type in 2019
Figure 39. China ED Treatment Sales Market Share by Application in 2019
Figure 40. Japan ED Treatment Sales Market Share by Company in 2019
Figure 41. Japan ED Treatment Sales Market Share by Type in 2019
Figure 42. Japan ED Treatment Sales Market Share by Application in 2019
Figure 43. Southeast Asia ED Treatment Sales Market Share by Company in 2019
Figure 44. Southeast Asia ED Treatment Sales Market Share by Type in 2019
Figure 45. Southeast Asia ED Treatment Sales Market Share by Application in 2019
Figure 46. India ED Treatment Sales Market Share by Company in 2019
Figure 47. India ED Treatment Sales Market Share by Type in 2019
Figure 48. India ED Treatment Sales Market Share by Application in 2019
Figure 49. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. BaiYunShan General Factory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. S.K. Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Teva Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Dong-A ST Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Metuchen Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Seoul Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. CSBIO. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of ED Treatment
Figure 61. Manufacturing Process Analysis of ED Treatment
Figure 62. ED Treatment Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed